Last reviewed · How we verify
NCT07299097: HYPNOS
Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
trial testing No intervention in Narcolepsy Type 1 in 100 participants. Currently enrolling.
30 May 2026
Quick facts
| Lead sponsor | Takeda |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 2 December 2025 |
| Primary completion | 30 May 2026 |
| Estimated completion | 30 May 2026 |
| Sites | 10 locations across Spain |
Drugs / interventions tested
- No intervention
Conditions studied
- Narcolepsy Type 1 — all drugs for Narcolepsy Type 1 →
- Narcolepsy Type 2 — all drugs for Narcolepsy Type 2 →
Sponsor
Takeda — full company profile →
Who can join
0 and older, any sex, with Narcolepsy Type 1 or Narcolepsy Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rare sleep disorder that causes excessive daytime sleepiness. The researchers will look at medical records from hospitals across Spain to count participants with these conditions and understand patterns in diagnosis over time.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07299097
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Narcolepsy Type 1
Currently open trials in the same condition.
- NCT07365566 — Pain Assessment in Patients With Idiopathic REM Sleep Behaviour Disorder · NA · recruiting
- NCT07096674 — A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia · Phase 2 · recruiting
- NCT06457945 — Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions · NA · recruiting
- NCT06484348 — Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcol · NA · recruiting
- NCT05816382 — A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions · Phase 2, PHASE3 · recruiting
Other Takeda trials
Trials by the same sponsor.
- NCT05669729 — A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velagluceras · not yet recruiting
- NCT07403968 — A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease · Phase 2 · not yet recruiting
- NCT07293364 — A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema · NA · not yet recruiting
- NCT07218393 — A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt · not yet recruiting
- NCT07445087 — A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07299097 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Takeda
- Last refreshed: 5 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07299097.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing